VERO FON: Open Payments
NPI 1326704479 · FRAMINGHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 4 payments from 3 companies in 2025. Trend: 2023 $39 · 2024 $350 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $129 |
| Alkermes, Inc. | 1 | $97 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
Products named: INGREZZA, LYBALVI, REXULTI.
Industry payments across MA — which companies pay providers there.
